These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


332 related items for PubMed ID: 27482839

  • 1. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.
    Liang G, Zhu Y, Jing A, Wang J, Hu F, Feng W, Xiao Z, Chen B.
    Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S, Zhang J, Wang Y, Chen M.
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.
    Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A.
    Cancer Res; 2011 Aug 01; 71(15):5214-24. PubMed ID: 21690566
    [Abstract] [Full Text] [Related]

  • 4. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S, Russo A, Pagliara V, Conte C, Ungaro F, Russo G, Quaglia F.
    J Nanobiotechnology; 2015 Apr 03; 13():29. PubMed ID: 25888948
    [Abstract] [Full Text] [Related]

  • 5. Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy.
    Zheng B, Chen L, Pan CC, Wang JZ, Lu GR, Yang SX, Xue ZX, Wang FY, Xu CL.
    Nanomedicine (Lond); 2018 Apr 01; 13(7):769-785. PubMed ID: 29460671
    [Abstract] [Full Text] [Related]

  • 6. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.
    Wang TY, Choe JW, Pu K, Devulapally R, Bachawal S, Machtaler S, Chowdhury SM, Luong R, Tian L, Khuri-Yakub B, Rao J, Paulmurugan R, Willmann JK.
    J Control Release; 2015 Apr 10; 203():99-108. PubMed ID: 25687306
    [Abstract] [Full Text] [Related]

  • 7. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S, Shao M, Zhong Z, Wang A, Cao J, Lu Y, Wang Y, Zhang J.
    Drug Deliv; 2017 Nov 10; 24(1):1791-1800. PubMed ID: 29172759
    [Abstract] [Full Text] [Related]

  • 8. Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs /PEI/miRNA/ HA Nanocomplexes.
    Yan LJ, Guo XH, Wang WP, Hu YR, Duan SF, Liu Y, Sun Z, Huang SN, Li HL.
    Curr Cancer Drug Targets; 2019 Nov 10; 19(4):330-337. PubMed ID: 30332960
    [Abstract] [Full Text] [Related]

  • 9. A novel type of self-assembled nanoparticles as targeted gene carriers: an application for plasmid DNA and antimicroRNA oligonucleotide delivery.
    Zhu Y, Liang G, Sun B, Tian T, Hu F, Xiao Z.
    Int J Nanomedicine; 2016 Nov 10; 11():399-410. PubMed ID: 26869785
    [Abstract] [Full Text] [Related]

  • 10. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K, Zhao J, Zhang Z, Gao Y, Zhou Y, Teng L, Li Y.
    Int J Pharm; 2016 Jan 30; 497(1-2):78-87. PubMed ID: 26617314
    [Abstract] [Full Text] [Related]

  • 11. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy.
    Gao S, Tian H, Guo Y, Li Y, Guo Z, Zhu X, Chen X.
    Acta Biomater; 2015 Oct 30; 25():184-93. PubMed ID: 26169933
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S, Qin H, Thomson KS, El-Bereir S, Cha SC, Neelapu S, Kwak LW, Roy K.
    J Control Release; 2006 Jul 20; 113(3):261-70. PubMed ID: 16793161
    [Abstract] [Full Text] [Related]

  • 13. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X, Iyer AK, Singh A, Milane L, Choy E, Hornicek FJ, Amiji MM, Duan Z.
    Pharm Res; 2015 Jun 20; 32(6):2097-109. PubMed ID: 25515492
    [Abstract] [Full Text] [Related]

  • 14. The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma.
    Cui FY, Song XR, Li ZY, Li SZ, Mu B, Mao YQ, Wei YQ, Yang L.
    Oncol Rep; 2010 Sep 20; 24(3):661-8. PubMed ID: 20664971
    [Abstract] [Full Text] [Related]

  • 15. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H, Cevher E, Alpar HO.
    Int J Pharm; 2009 Mar 18; 369(1-2):144-54. PubMed ID: 19010405
    [Abstract] [Full Text] [Related]

  • 16. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
    Cai C, Xie Y, Wu L, Chen X, Liu H, Zhou Y, Zou H, Liu D, Zhao Y, Kong X, Liu P.
    Sci Rep; 2017 Apr 07; 7():46250. PubMed ID: 28387375
    [Abstract] [Full Text] [Related]

  • 17. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M, Sapin A, Arıca-Yegin B, Merlin JL, Becuwe P, Maincent P.
    Int J Pharm; 2011 Jan 17; 403(1-2):276-84. PubMed ID: 21044878
    [Abstract] [Full Text] [Related]

  • 18. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
    Xia Y, Guo M, Xu T, Li Y, Wang C, Lin Z, Zhao M, Zhu B.
    Int J Nanomedicine; 2018 Jan 17; 13():1539-1552. PubMed ID: 29588583
    [Abstract] [Full Text] [Related]

  • 19. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
    Song C, Noh YW, Lim YT.
    Int J Nanomedicine; 2016 Jan 17; 11():3753-64. PubMed ID: 27540289
    [Abstract] [Full Text] [Related]

  • 20. PEGylated composite nanoparticles of PLGA and polyethylenimine for safe and efficient delivery of pDNA to lungs.
    Kolte A, Patil S, Lesimple P, Hanrahan JW, Misra A.
    Int J Pharm; 2017 May 30; 524(1-2):382-396. PubMed ID: 28391040
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.